Neuro-Oncology Advances: Brain Metastases Supplement
This activity is jointly provided by Global Education Group and the Society for Neuro-Oncology.
This activity is supported by an educational grant from Novocure, Inc. and Seagen, Inc.
In order to receive credit for this activity, the participant must read all of the journal articles, score 70% or better on the posttest, and complete the activity evaluation.
IMPORTANT NOTE: Learners should not complete this posttest, evaluation, or claim CME credit for this activity without first reading the entire supplement. To access the articles in the supplement at no charge, please visit the Oxford University Publishing website here: https://academic.oup.com/noa/issue/3/Supplement_5.
The educational design of this activity addresses the needs of Neuro-Oncologists, Medical Oncologists, Neurosurgeons, Radiation Oncologists, Radiologists, Physicians/Scientists, Clinical and Laboratory Trainees with an interest.
After completing this activity, the participant should be better able to:
- Explain advances in neurosurgical interventions used in patients with metastatic brain tumors.
- Identify indications for laser interstitial thermal therapy in treating metastases to the brain.
- Describe advances in radiation therapy for the treatment of intracranial metastases.
- Summarize current targeted therapy options for brain and leptomeningeal metastases.
- Discuss the role for immunotherapy in managing patients with intracranial metastases.
- Outline potential therapy induced neurological morbidities.
- Recognize approaches used to preserve patient neuro-cognitive function.
- Describe treatment challenges associated with the tumor microenvironment.
- Explain the impact of the blood-tumor barrier on the intracranial penetrance of systemic therapies.
- Discuss animals models of brain metastasis used to evaluate novel therapies.
- 6.00 AMA PRA Category 1 Credit™This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Society for Neuro-Oncology. Global is accredited by the ACCME to provide continuing medical education for physicians.
- 6.00 Attendance